| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| ln Vitro |
C6 neuroastroma cells are exposed to radiation cues when exposed to isisquinone (0–128 nM, 12-48 h) [2]. In Stowe C6 neuroastroma cells, irisquinone (4.2 nM, 48 h) amplifies radioactive cues [2].
|
|---|---|
| ln Vivo |
Irisquinone (12.5 mg/kg, daily infusion) made the tumor wall thinner and the abdomen area increased in the Irisquinone + radiation group in the rabbit VX2 lung transplant tumor model [1].
|
| Cell Assay |
Cell Viability Assay[2]
Cell Types: C6 Rat Glioma Cells Tested Concentrations: 0, 4, 8, 16, 32, 64, 128 nM Incubation Duration: 12, 24, 48 hrs (hours) Experimental Results: Time-dependent and dose-dependent Sexually inhibit cell viability. |
| Animal Protocol |
Animal/Disease Models: Rabbits bearing VX2 lung transplant tumors [1]
Doses: 12.5 mg/kg Route of Administration: daily infusion from 3 days before irradiation to the end of irradiation. Experimental Results: There was no significant difference in tumor growth between the radiotherapy group and the irisquinone + radiotherapy group. The tumor wall in the irisquinone + radiotherapy group was thinner and the necrosis area was larger. |
| References |
|
| Additional Infomation |
Irisquinone has been reported in Iris missouriensis, Iris sibirica, and other organisms with data available.
|
| Molecular Formula |
C24H38O3
|
|---|---|
| Molecular Weight |
374.55672
|
| Exact Mass |
374.282
|
| CAS # |
56495-82-0
|
| PubChem CID |
5318483
|
| Appearance |
Typically exists as solid at room temperature
|
| Density |
0.97g/cm3
|
| Boiling Point |
483.4ºC at 760mmHg
|
| Flash Point |
205.1ºC
|
| Index of Refraction |
1.498
|
| LogP |
6.632
|
| Hydrogen Bond Donor Count |
0
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
16
|
| Heavy Atom Count |
27
|
| Complexity |
526
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
CCCCCCC=CCCCCCCCCCC1=CC(=O)C=C(C1=O)OC
|
| InChi Key |
YYCCUFKHCNSRIA-HJWRWDBZSA-N
|
| InChi Code |
InChI=1S/C24H38O3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-21-19-22(25)20-23(27-2)24(21)26/h8-9,19-20H,3-7,10-18H2,1-2H3/b9-8-
|
| Chemical Name |
2-[(Z)-heptadec-10-enyl]-6-methoxycyclohexa-2,5-diene-1,4-dione
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.6698 mL | 13.3490 mL | 26.6980 mL | |
| 5 mM | 0.5340 mL | 2.6698 mL | 5.3396 mL | |
| 10 mM | 0.2670 mL | 1.3349 mL | 2.6698 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
